A detailed history of Canada Pension Plan Investment Board transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 172,200 shares of HALO stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
172,200
Previous 172,200 -0.0%
Holding current value
$10.3 Million
Previous $7.01 Million 28.71%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$33.32 - $42.1 $4.1 Million - $5.18 Million
123,000 Added 250.0%
172,200 $6.36 Million
Q3 2023

Nov 09, 2023

SELL
$36.46 - $44.03 $616,174 - $744,107
-16,900 Reduced 25.57%
49,200 $1.88 Million
Q2 2023

Aug 09, 2023

BUY
$30.28 - $38.74 $702,496 - $898,768
23,200 Added 54.08%
66,100 $2.38 Million
Q1 2023

May 12, 2023

BUY
$32.86 - $55.7 $1.41 Million - $2.39 Million
42,900 New
42,900 $1.64 Million
Q2 2022

Aug 12, 2022

SELL
$37.35 - $48.3 $9,598 - $12,413
-257 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$31.97 - $41.06 $440,322 - $565,519
-13,773 Reduced 98.17%
257 $10,000
Q4 2021

Feb 14, 2022

BUY
$31.82 - $40.75 $297,039 - $380,401
9,335 Added 198.83%
14,030 $564,000
Q3 2021

Nov 15, 2021

BUY
$38.47 - $46.42 $136,722 - $164,976
3,554 Added 311.48%
4,695 $191,000
Q2 2021

Aug 16, 2021

BUY
$38.84 - $51.31 $44,316 - $58,544
1,141 New
1,141 $52,000
Q1 2021

May 17, 2021

SELL
$39.51 - $51.45 $264,717 - $344,715
-6,700 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$25.81 - $43.62 $172,927 - $292,254
6,700 New
6,700 $286,000
Q3 2020

Nov 12, 2020

SELL
$25.74 - $29.63 $2.99 Million - $3.44 Million
-116,100 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$16.25 - $26.81 $1.89 Million - $3.11 Million
116,100 New
116,100 $3.11 Million
Q1 2020

May 13, 2020

SELL
$13.9 - $21.83 $2.32 Million - $3.65 Million
-167,100 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$14.93 - $19.53 $2.49 Million - $3.26 Million
167,100 New
167,100 $2.96 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.31B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.